Local oestrogen for vaginal atrophy in postmenopausal women
about
Interventions for sexual dysfunction following treatments for cancer in womenDecision aids for the management of menopausal symptomsLong term hormone therapy for perimenopausal and postmenopausal womenHormone therapy for sexual function in perimenopausal and postmenopausal womenShort and long term effects of tibolone in postmenopausal womenOestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal womenInterventions for sexual dysfunction following treatments for cancerOestrogens for preventing recurrent urinary tract infection in postmenopausal womenThe Recent Review of the Genitourinary Syndrome of MenopauseLocal Oestrogen for Pelvic Floor Disorders: A Systematic ReviewMultidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal womenClinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophyLong-term hormone therapy for perimenopausal and postmenopausal women.Vulvovaginal atrophy.TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol.A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapyUltra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.The 2012 hormone therapy position statement of: The North American Menopause Society.What do portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based surveyAssociation between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.Using Wood's Light as a Diagnostic Tool for Vaginal Atrophy.Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.Survivorship: sexual dysfunction (female), version 1.2013.Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy.Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator.Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopauseThe effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic reviewOvercoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophyLichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.Barriers to effective treatment of vaginal atrophy with local estrogen therapy.Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy.Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report.Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.Effect of a gel containing pilocarpine on vaginal atrophy in castrated rats.Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal WomenBreast cancer in young women and its impact on reproductive functionDyspareunia in postmenopausal women: a critical review.
P2860
Q24186175-B69F5A86-A4B0-4EAC-8849-6B29653C0789Q24187423-14A0F8F8-6B78-42E5-B19B-65D7C5242645Q24201974-EEAECAB3-19D1-485D-87B8-2C06C689D93BQ24202201-0CAD46F6-6AE3-4331-9397-210FC88C260DQ24203695-7E7044C7-5551-4605-961E-B47C631F34BEQ24235377-E3AF7C18-7FE8-4ECC-8615-60529A5E3141Q24242883-B9D782C0-79EB-467C-BA5B-6976FF68AB9FQ24243182-932F13B2-10C3-43EB-8BC9-7E3485651B11Q26781733-E6E54D87-BD49-460A-B577-943DBCEB76B3Q26783453-3CBCF753-BC39-45E2-90C2-1D766FC8F18AQ26828795-B0BF9DD5-D366-4B92-9B76-80EFF6B1334FQ28066699-B948A280-BD6A-4212-831A-A65EFE9B465DQ30238978-584F5E23-4AAC-4480-8596-D715869296F9Q33566744-7C7D9EB8-A4ED-47F2-82C7-793BF15D8B85Q33601408-34E98886-D76F-47F9-A96F-2B42E31BF9A2Q33605919-D72A3F74-1D15-4452-A2EE-4B7221DB0888Q33628455-6C5BCC8B-1F88-4952-BEA9-C059C393D733Q33858050-C307D344-7574-44F7-AC20-3182D6B9686BQ34161400-B6246629-126D-4702-B2DE-63B052AD9329Q34785676-7D09B841-01BF-4550-A006-62EB6BA175F1Q35002766-0CD6B3C2-C683-42CA-9BAB-9790E58EA77AQ35139754-6001C078-0AC2-4CB8-8E77-F20B210E057AQ35584556-7A6280A8-8FBC-47E9-8E37-6FE046B7E075Q35735025-3C88A2A5-746A-4EC0-9521-FA935F204423Q35885187-B0ADCAB0-B641-4828-8EC5-247237817F83Q36049247-2438466C-6A49-492E-BF0E-B71D32A16ED5Q36095148-250BD549-69E1-4643-8B3D-7FE7D7A53022Q36108656-8F61024A-BC72-4CB5-BF59-6F72AF4760EAQ36315490-3D18691D-2B05-4A83-974B-74B4ED409E82Q36326412-E388464F-395C-49B6-863E-6B05B6EC488CQ36688701-6430ED51-1CB0-405F-9683-55EF9E00027CQ36702052-FA9CEC97-6451-439C-B5BA-05085A156324Q36706621-74F3CA70-C018-42AB-BD37-5DF1C428AF80Q36711672-0662FC70-570D-4871-A970-B8C79A48872DQ36762596-7D855FDC-FD09-45A3-AA3F-581D2C27FBFAQ36810368-7A02DEDA-6272-48D1-BCD7-C9EC22BDCFBBQ36920585-AF006102-C503-4607-A873-7AF4CE8EDE9BQ37102836-C7D5035C-8086-4B28-87A8-3B88342488B4Q37153908-72D7E04A-C415-4D32-80A1-AF16315ADAB8Q37164377-F6EFA067-C7D6-455C-99AD-512D97DF69CE
P2860
Local oestrogen for vaginal atrophy in postmenopausal women
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Local oestrogen for vaginal atrophy in postmenopausal women
@ast
Local oestrogen for vaginal atrophy in postmenopausal women
@en
Local oestrogen for vaginal atrophy in postmenopausal women
@en-gb
Local oestrogen for vaginal atrophy in postmenopausal women
@nl
type
label
Local oestrogen for vaginal atrophy in postmenopausal women
@ast
Local oestrogen for vaginal atrophy in postmenopausal women
@en
Local oestrogen for vaginal atrophy in postmenopausal women
@en-gb
Local oestrogen for vaginal atrophy in postmenopausal women
@nl
prefLabel
Local oestrogen for vaginal atrophy in postmenopausal women
@ast
Local oestrogen for vaginal atrophy in postmenopausal women
@en
Local oestrogen for vaginal atrophy in postmenopausal women
@en-gb
Local oestrogen for vaginal atrophy in postmenopausal women
@nl
P2093
P2860
P3181
P1476
Local oestrogen for vaginal atrophy in postmenopausal women
@en
P2093
Helen Roberts
Jane A Suckling
Ray Kennedy
P2860
P3181
P356
10.1002/14651858.CD001500.PUB2
P50
P577
2006-10-18T00:00:00Z